Nucala 100 MG/ML auto-injectorml
Ended Awarded
- Contract number
- SPE2DB25FH5DK
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $22,715
Award facts
- Contract value 100% obligated
- $22,714.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $22,714.80 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Nucala 100 mg/ml auto-injectors. The contract, with an ultimate completion date of August 18, 2025, represents a direct delivery order issued under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with DLA valued at $499,999,999 and effective through November 2026. No set-aside designation was applied to this specific delivery order. DMS Pharmaceutical Group leverages its established position as a federal pharmaceutical supplier to compete effectively in open procurement markets, supported by its woman-owned small business status and SAM.gov registration dating to 2001.
DMS Pharmaceutical Group serves as a critical supplier within the federal pharmaceutical supply chain, providing comprehensive distribution of branded and generic prescription drugs, biologics, and medical consumables to Department of Defense healthcare facilities nationwide. The company's extensive contract portfolio with DLA demonstrates consistent capability in delivering specialized pharmaceutical products including injections, auto-injectors, and specialty medications to support military health system requirements. The underlying Indefinite Delivery Contract vehicle enables DLA to issue firm fixed-price delivery orders across a broad range of pharmaceutical items, with this Nucala order exemplifying the types of targeted medical supplies distributed through this arrangement to support DOD healthcare operations.
Quick answers
Who was awarded contract SPE2DB25FH5DK?
SPE2DB25FH5DK was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 15, 2025.
How much is contract SPE2DB25FH5DK worth?
The government has obligated $22,715 on SPE2DB25FH5DK.
Is contract SPE2DB25FH5DK an order under another contract?
Yes. SPE2DB25FH5DK is a delivery order under SPE2DB22D9207, an indefinite delivery contract.
Was contract SPE2DB25FH5DK competed?
The extent of competition for SPE2DB25FH5DK was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award